Cargando…

Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model

BACKGROUND: Omega-3 fatty acids (Ω-3 PUFAs) may help to improve health status in polycystic ovarian syndrome (PCOS) by reducing numerous metabolic disorders (insulin sensitivity, hyperinsulinemia, lipid profile, obesity and inflammation). To evaluate the current objective, 16 weeks (6 weeks of adjus...

Descripción completa

Detalles Bibliográficos
Autores principales: Komal, Fiza, Khan, Muhammad Kamran, Imran, Muhammad, Ahmad, Muhammad Haseeb, Anwar, Haseeb, Ashfaq, Usman Ali, Ahmad, Nazir, Masroor, Amna, Ahmad, Rabia Shabir, Nadeem, Muhammad, Nisa, Mahr Un
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491187/
https://www.ncbi.nlm.nih.gov/pubmed/32928224
http://dx.doi.org/10.1186/s12967-020-02519-1
_version_ 1783582171316879360
author Komal, Fiza
Khan, Muhammad Kamran
Imran, Muhammad
Ahmad, Muhammad Haseeb
Anwar, Haseeb
Ashfaq, Usman Ali
Ahmad, Nazir
Masroor, Amna
Ahmad, Rabia Shabir
Nadeem, Muhammad
Nisa, Mahr Un
author_facet Komal, Fiza
Khan, Muhammad Kamran
Imran, Muhammad
Ahmad, Muhammad Haseeb
Anwar, Haseeb
Ashfaq, Usman Ali
Ahmad, Nazir
Masroor, Amna
Ahmad, Rabia Shabir
Nadeem, Muhammad
Nisa, Mahr Un
author_sort Komal, Fiza
collection PubMed
description BACKGROUND: Omega-3 fatty acids (Ω-3 PUFAs) may help to improve health status in polycystic ovarian syndrome (PCOS) by reducing numerous metabolic disorders (insulin sensitivity, hyperinsulinemia, lipid profile, obesity and inflammation). To evaluate the current objective, 16 weeks (6 weeks of adjustment period followed by 10 weeks of collection period) research trial was planned to check the impact of different sources of Ω-3 PUFAs (synthetic Ω-3, flaxseed and fish oil) on nutrient digestibility, weight gain, productive (lipid profile, glucose and insulin), reproductive profile (progesterone, follicle stimulating hormone (FSH), estrogen, luteinizing hormone (LH) and prolactin) and histological study of ovarian tissues in Wistar female rats. METHODS: Forty-five rats of 130 ± 10 g weight were divided into 5 groups, each having 9 rats: NC (negative control without PCOS), PC (positive control with PCOS), SO (synthetic omega-3 containing ALA, EPA and DHA), FO (flaxseed oil) and F (fish oil) fed at 300 mg/kg/orally/daily of these sources were added in the basal diets while PC and NC received only the basal diet. Food and water were offered ad libitum. PCOS was induced in the rats fed of PC, SO, FO and F diets group by single intramuscular injection of estradiol-valerate (4 mg/rat/IM). Body weight and blood glucose was recorded weekly. At 16(th) week of trial, blood samples were collected for lipid and hormonal analysis. Ovarian tissues were removed for pathological evaluation. Digestibility was measured by total collection method. RESULTS: Cholesterol, triglycerides and low-density lipoproteins were reduced in SO, FO and F groups when compared with rats of PC group. However, increasing trend of high-density lipoprotein (HDL) was found in same groups. The highest HDL (36.83 ± 0.72 mg/dL) was observed in rats fed F diet. In case of a hormonal profile, testosterone, LH and insulin levels showed a significant reduction after treatments. Blood glucose results showed significantly reducing trend in all the rats fed with Ω-3 PUFAs sources than PC from 5 to 10th week of trial. However, similar trend was noticed in rat’s body weight at the end of 6th week. In ovarian morphology, different stages of follicles were observed in groups fed SO, FO and F diets. Nutrient digestibility in PCOS induced rats was remained non-significant. CONCLUSIONS: The three sources of Ω-3 PUFAs had effective role in improving lipid and hormonal profile, reducing blood glucose, weight gain and histopathological damages in PCOS rats. However, fish oil source might be an innovative approach to cure PCOS via reducing the weight and metabolic anomalies due to EPA and DHA.
format Online
Article
Text
id pubmed-7491187
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74911872020-09-16 Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model Komal, Fiza Khan, Muhammad Kamran Imran, Muhammad Ahmad, Muhammad Haseeb Anwar, Haseeb Ashfaq, Usman Ali Ahmad, Nazir Masroor, Amna Ahmad, Rabia Shabir Nadeem, Muhammad Nisa, Mahr Un J Transl Med Research BACKGROUND: Omega-3 fatty acids (Ω-3 PUFAs) may help to improve health status in polycystic ovarian syndrome (PCOS) by reducing numerous metabolic disorders (insulin sensitivity, hyperinsulinemia, lipid profile, obesity and inflammation). To evaluate the current objective, 16 weeks (6 weeks of adjustment period followed by 10 weeks of collection period) research trial was planned to check the impact of different sources of Ω-3 PUFAs (synthetic Ω-3, flaxseed and fish oil) on nutrient digestibility, weight gain, productive (lipid profile, glucose and insulin), reproductive profile (progesterone, follicle stimulating hormone (FSH), estrogen, luteinizing hormone (LH) and prolactin) and histological study of ovarian tissues in Wistar female rats. METHODS: Forty-five rats of 130 ± 10 g weight were divided into 5 groups, each having 9 rats: NC (negative control without PCOS), PC (positive control with PCOS), SO (synthetic omega-3 containing ALA, EPA and DHA), FO (flaxseed oil) and F (fish oil) fed at 300 mg/kg/orally/daily of these sources were added in the basal diets while PC and NC received only the basal diet. Food and water were offered ad libitum. PCOS was induced in the rats fed of PC, SO, FO and F diets group by single intramuscular injection of estradiol-valerate (4 mg/rat/IM). Body weight and blood glucose was recorded weekly. At 16(th) week of trial, blood samples were collected for lipid and hormonal analysis. Ovarian tissues were removed for pathological evaluation. Digestibility was measured by total collection method. RESULTS: Cholesterol, triglycerides and low-density lipoproteins were reduced in SO, FO and F groups when compared with rats of PC group. However, increasing trend of high-density lipoprotein (HDL) was found in same groups. The highest HDL (36.83 ± 0.72 mg/dL) was observed in rats fed F diet. In case of a hormonal profile, testosterone, LH and insulin levels showed a significant reduction after treatments. Blood glucose results showed significantly reducing trend in all the rats fed with Ω-3 PUFAs sources than PC from 5 to 10th week of trial. However, similar trend was noticed in rat’s body weight at the end of 6th week. In ovarian morphology, different stages of follicles were observed in groups fed SO, FO and F diets. Nutrient digestibility in PCOS induced rats was remained non-significant. CONCLUSIONS: The three sources of Ω-3 PUFAs had effective role in improving lipid and hormonal profile, reducing blood glucose, weight gain and histopathological damages in PCOS rats. However, fish oil source might be an innovative approach to cure PCOS via reducing the weight and metabolic anomalies due to EPA and DHA. BioMed Central 2020-09-14 /pmc/articles/PMC7491187/ /pubmed/32928224 http://dx.doi.org/10.1186/s12967-020-02519-1 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Komal, Fiza
Khan, Muhammad Kamran
Imran, Muhammad
Ahmad, Muhammad Haseeb
Anwar, Haseeb
Ashfaq, Usman Ali
Ahmad, Nazir
Masroor, Amna
Ahmad, Rabia Shabir
Nadeem, Muhammad
Nisa, Mahr Un
Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title_full Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title_fullStr Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title_full_unstemmed Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title_short Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model
title_sort impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in pcos rat model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7491187/
https://www.ncbi.nlm.nih.gov/pubmed/32928224
http://dx.doi.org/10.1186/s12967-020-02519-1
work_keys_str_mv AT komalfiza impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT khanmuhammadkamran impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT imranmuhammad impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT ahmadmuhammadhaseeb impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT anwarhaseeb impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT ashfaqusmanali impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT ahmadnazir impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT masrooramna impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT ahmadrabiashabir impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT nadeemmuhammad impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel
AT nisamahrun impactofdifferentomega3fattyacidsourcesonlipidhormonalbloodglucoseweightgainandhistopathologicaldamagesprofileinpcosratmodel